Stacy Krisher, MD
Surgical Oncology · Bensalem, PANPI 1023037546
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (52.0%), speaking fees and food and beverage — rather than concentrated in one kind of arrangement. 9 manufacturers reported payments, led by Cardinal Health 414 LLC at 52.0% of the total. Reporting peaked in 2019 at $4,900 and has fallen 94.4% since, to $274 in 2025. Among surgical oncology clinicians in PA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 26 payments — averaging $362.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Cardinal Health 414 LLC$5K
- Medtronic$3K
- Dilon Technologies, Inc.$493
- Endomagnetics Ltd$401
- Myriad Genetic Laboratories, Inc.$309
- Leica Microsystems Inc.$201
- plus $93 from 3 others
What the payments were for
- Consulting fees$4,90052%
- Speaking & faculty fees$3,00032%
- Food & beverage$1,52916%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Cardinal Health 414 LLC | 1 | $4,900 |
| Medtronic | 2 | $3,032 |
| Dilon Technologies, Inc. | 3 | $493 |
| Endomagnetics Ltd | 6 | $401 |
| Myriad Genetic Laboratories, Inc. | 7 | $309 |
| Leica Microsystems Inc. | 4 | $201 |
| Hologic Sales And Service, LLC | 1 | $41 |
| Solventum Corporation | 1 | $35 |
| Pacira Pharmaceuticals Incorporated | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Lymphoseek$4,900
- AQUAMANTYS$3,000
- HemoBlast Bellows$493
- Magseed$282
- Magtrace$282
- NEOPROBE$143
- myRisk$115
How this compares
$9,429 in reported general payments places this provider in the 90th percentile of 78 surgical oncology providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ibuprofen | 19 | $49 |
| Oxycodone Hcl | 11 | $14 |
Paid to pharmacies, not to this prescriber.
Other surgical oncology in Bensalem
- Richard BleicherPhiladelphia$53K
- Catherine CarruthersSouthampton$17K
- Nestor EsnaolaPhiladelphia$17K
- Andrea PorpigliaPhiladelphia$11K
- William MoranoWynnewood$11K
- Matthew HoltzmanPittsburgh$11K
- Arvind SabesanWynnewood$10K
- Amer ZureikatPittsburgh$9K
- Roderick QuirosEaston$8K
- Jandie PosnerChester$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.